Although recent advancements in next-generation sequencing technology have improved our understanding of the biology of prostate tumors [12], emphasizing the genetic basis of clinical variability of the disease, the impact of the molecular heterogeneity of PCa on the IGF axis has never been considered at clinical level. Here, IGF1 is linked to posterior cortical atrophy.